Mood disorders are a group of psychiatric conditions whose defining feature is a persistent disturbance in emotional state, whether that means prolonged sadness, elevated or irritable mood, or unstable cycling between the two. The two major diagnostic systems used worldwide, the DSM-5 and the ICD-11, organize them into roughly the same framework: depressive disorders on one side, bipolar and related disorders on the other, with several more specialized diagnoses filling the gaps.1PubMed. Convergences and Divergences in the ICD-11 vs. DSM-5 Classification of Mood Disorders The full list is longer and more varied than most people expect, and several entries are frequently misunderstood or confused with one another.
Major Depressive Disorder
Major depressive disorder (MDD) is the condition most people picture when they hear “mood disorder.” It is defined by at least one major depressive episode: two or more weeks of low mood or an inability to feel pleasure, combined with changes in sleep, appetite, energy, concentration, or self-worth severe enough to impair daily life.2CMAJ. Neurobiological mechanisms in major depressive disorder A person can be diagnosed after just one such episode, as long as they have never experienced mania or hypomania. Both the DSM-5 and ICD-11 now set the threshold at five or more symptoms during the episode.3PubMed. Convergences and Divergences in the ICD-11 vs. DSM-5 Classification of Mood Disorders
The biology behind MDD is not pinned to a single broken switch. Research links it to changes in brain volume (especially in the hippocampus), disrupted activity in circuits that govern attention and emotional processing, problems with the body’s stress-response system, and shifts in immune function.4PubMed Central. Major depressive disorder The point worth remembering is that depression is not simply a “chemical imbalance” in one neurotransmitter. It involves multiple overlapping systems, which helps explain why no single treatment works for everyone.
Persistent Depressive Disorder
If MDD is a storm, persistent depressive disorder (PDD) is an overcast sky that never quite clears. Under the DSM-5, this diagnosis rolls together what used to be called dysthymia, chronic major depression, and recurrent major depression without full recovery between episodes.5PubMed. Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications The symptoms are milder on any given day than a full major depressive episode, but they grind on for at least two years in adults. One of the reasons PDD often goes undiagnosed is that its hallmark is a persistent low-level flatness, dominated by loss of interest and apathy, that people come to see as just “how they are” rather than a treatable condition.6PubMed Central. Dysthymia and apathy: diagnosis and treatment Despite being less dramatic than episodic depression, PDD is often more disabling over time because the person never gets a sustained break from it.7PubMed. Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications
Disruptive Mood Dysregulation Disorder
Disruptive mood dysregulation disorder (DMDD) is a relatively new addition, introduced in the DSM-5’s depressive disorders section. It applies only to children and adolescents and was created to address a real clinical problem: kids with chronic, severe irritability and frequent explosive temper outbursts were being diagnosed with bipolar disorder, even though their symptoms did not come and go in distinct episodes the way bipolar illness does.8PubMed. Focus on Disruptive Mood Dysregulation Disorder: A review of the literature The core features are severe temper outbursts, verbal or physical, occurring three or more times a week, against a background of persistently irritable or angry mood between outbursts. Symptoms must be present by age ten, and the diagnosis cannot be made before age six.9PubMed Central. Disruptive Mood Dysregulation Disorder Among Children and Adolescents
DMDD can coexist with ADHD, conduct disorder, and substance use disorder, but it specifically rules out a simultaneous diagnosis of oppositional defiant disorder or intermittent explosive disorder to avoid double-counting the same behaviors.10PubMed Central. Disruptive Mood Dysregulation Disorder Among Children and Adolescents The distinction from pediatric bipolar disorder matters for treatment: bipolar disorder is managed with mood stabilizers and sometimes antipsychotics, whereas DMDD treatment typically involves behavioral therapy and, when medication is used, often targets the irritability rather than cycling mood.
Premenstrual Dysphoric Disorder
Premenstrual dysphoric disorder (PMDD) sits in the depressive disorders section of the DSM-5, though it follows a distinctive hormonal rhythm. Symptoms, which include marked mood swings, irritability, anxiety, and depressive feelings, appear during the luteal phase of the menstrual cycle (after ovulation) and resolve within a few days of menstruation. What separates PMDD from ordinary premenstrual moodiness is severity: the symptoms cause significant distress or interfere with work, school, or relationships.
The underlying problem is not abnormal hormone levels per se. Research points instead to an abnormal central nervous system response to normal fluctuations in ovarian steroids, particularly the way the brain’s inhibitory signaling system reacts to allopregnanolone, a neurosteroid derived from progesterone.11PubMed Central. Towards understanding the biology of premenstrual dysphoric disorder: From genes to GABA 12PubMed Central. Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome In other words, the hormones themselves are normal; it is the brain’s sensitivity to them that differs. This matters practically because treatment strategies often target the brain’s response rather than suppressing the hormones entirely, though both approaches exist.
Bipolar I Disorder
Bipolar I disorder is defined by at least one lifetime manic episode, a period of abnormally elevated, expansive, or irritable mood with increased energy lasting at least seven days (or requiring hospitalization). Depressive episodes occur in most people with bipolar I, but they are not required for the diagnosis. The illness is chronic, characterized by alternation between mania, depression, and sometimes mixed states, and often associated with significant functional impairment.13PubMed Central. Neurobiology of bipolar disorders: a review of genetic components, signaling pathways, biochemical changes, and neuroimaging findings
Brain imaging research in mania has identified a pattern of reduced activity in the right ventral prefrontal cortex and increased activity in the left amygdala and left basal ganglia, suggesting that manic episodes involve a lateralized disruption of circuits that regulate emotion.14Translational Psychiatry. Functional neuroanatomy of mania Despite decades of study, though, diagnosis remains clinical. There is no blood test or brain scan that confirms bipolar disorder; clinicians rely on the history and pattern of episodes.
Bipolar II Disorder
Bipolar II is often mistakenly viewed as a milder version of bipolar I. It is a distinct subtype, recognized in both the DSM-5 and ICD-11, defined by at least one depressive episode and at least one hypomanic episode, with no history of full mania.15PubMed Central. Bipolar II disorder: a state-of-the-art review Hypomania is a shorter, less severe version of mania: mood is elevated and energy is up, but the person can usually still function, and hospitalization is not needed.
The “milder” label is misleading because the depressive burden of bipolar II is enormous. Patients with bipolar II experience depressive episodes that outnumber hypomanic episodes by a ratio of roughly 39 to 1.16PubMed Central. Bipolar II disorder: a state-of-the-art review That means the person spends the vast majority of their illness in a depressive state, and the occasional hypomania may even feel productive and pleasant by comparison, making it easy to miss. The real challenge is that bipolar II depression looks almost identical to unipolar major depression from the outside, which is why misdiagnosis is common and why clinicians need to ask specifically about past episodes of elevated mood.
Cyclothymic Disorder
Cyclothymia occupies the lower end of the bipolar spectrum. It involves chronic, fluctuating mood disturbance with numerous periods of hypomanic-like symptoms and periods of depressive symptoms over at least two years (one year in children), but the highs and lows never meet the full criteria for a hypomanic or major depressive episode. The result is a kind of emotional instability that the person and those around them may interpret as “just their personality” rather than a diagnosable condition.
Cyclothymia matters because it may serve as a stepping stone to more severe bipolar illness. Research describes it as a potential foundation for more acute presentations of bipolar disorder, giving it an important role in understanding how mood disorders develop over time.17PubMed Central. Cyclothymic disorder in youth: why is it overlooked, what do we know and where is the field headed? Whether and how often cyclothymia progresses to bipolar I or II remains an open question, partly because the follow-up periods in existing studies of young people have been too short to draw firm conclusions.18PubMed Central. Longitudinal course and characteristics of cyclothymic disorder in youth
Mixed Episodes and Where the Systems Disagree
One area where the DSM-5 and ICD-11 deliberately part ways involves mixed states, episodes in which depressive and manic or hypomanic symptoms coexist. The ICD-11 kept mixed episodes as a stand-alone category. The DSM-5 replaced them with a “mixed features” specifier that can be attached to a depressive, manic, or hypomanic episode. The ICD-11 approach appears to be more inclusive, capturing patients who meet criteria for both sets of symptoms simultaneously, while the DSM-5 specifier has a narrower gate.19PubMed Central. Bipolar disorder in the International Classification of Diseases-Eleventh version: A review of the changes, their basis, and usefulness For people who experience these overlapping states, the difference is not just academic: mixed presentations carry a higher suicide risk and often require different medication choices than pure mania or pure depression.
Seasonal Pattern and the Role of Light
Seasonal affective disorder (SAD), formally a “seasonal pattern” specifier rather than a standalone diagnosis, describes recurrent depressive episodes that follow a seasonal pattern, most commonly appearing in fall or winter and remitting in spring. The underlying mechanism involves shifts in the body’s circadian rhythm and changes in serotonin activity triggered by reduced daylight exposure.20PubMed Central. Bright Light Therapy: Seasonal Affective Disorder and Beyond
Actigraphy studies, which track physical activity around the clock using wrist-worn sensors, show that people with SAD have substantially lower daytime activity and a sleep-wake rhythm that is delayed by about 55 minutes compared to healthy controls. After four weeks of bright light therapy, daytime activity increased, the delayed rhythm shifted earlier, and sleep quality improved.21PubMed. Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapy Bright light therapy remains one of the better-supported treatments for seasonal depression, though it is also being explored for non-seasonal mood disorders.
Peripartum Depression
The DSM-5 uses a “peripartum onset” specifier to identify major depressive or manic episodes that begin during pregnancy or within four weeks of delivery, though many clinicians and researchers use a broader window extending to the first year postpartum. The hormonal explanation is straightforward in outline: estradiol and progesterone levels rise dramatically during pregnancy and then crash after delivery, and this rapid swing appears to trigger depression in women whose brains are particularly sensitive to those changes.22PubMed Central. THE NEUROENDOCRINOLOGICAL ASPECTS OF PREGNANCY AND POSTPARTUM DEPRESSION
Research suggests, however, that not all peripartum depression is the same. The fluctuations in reproductive hormones interact with thyroid function, immune responses, and the stress-response system to produce what may be several distinct subtypes. One group of researchers has proposed a “hormone-sensitive” phenotype: women who are especially vulnerable to mood disruption from normal hormonal changes, and who may need different treatment approaches than women whose postpartum depression has more to do with sleep deprivation, social isolation, or prior psychiatric history.23PubMed Central. The role of reproductive hormones in postpartum depression
Mood Disorders Due to Another Medical Condition
Both diagnostic systems include a category for mood disturbances that are a direct physiological consequence of a medical condition. Thyroid disorders are the textbook example. Hypothyroidism is linked to depression through shared pathways involving serotonin and the hormonal axis connecting the hypothalamus, pituitary gland, and thyroid.24PubMed Central. Hypothyroidism and Depression: A Narrative Review In practice, this means that anyone presenting with new or treatment-resistant depressive symptoms should have basic thyroid function checked before assuming the depression is purely psychiatric. Other medical conditions that can produce mood symptoms include neurological disorders, autoimmune diseases, and certain cancers, especially those affecting the brain or endocrine system.
There is also a substance- or medication-induced mood disorder category, which covers depressive or manic symptoms that are a direct result of intoxication, withdrawal, or medication side effects. Corticosteroids, interferon, and some blood pressure medications are well-known culprits. The key diagnostic question is always timing: did the mood symptoms start or worsen in clear relationship to the substance or medical condition?
The Shared Biology Underneath
A common thread running through these disorders is the body’s stress-response system. Chronic stress drives prolonged activation of the hormonal pathway connecting the hypothalamus, pituitary, and adrenal glands, which in turn disrupts cortisol regulation. Over time, this can fuel inflammation, damage neurons (particularly in the hippocampus), and worsen depressive symptoms.25PubMed Central. Chronic Stress-Associated Depressive Disorders: The Impact of HPA Axis Dysregulation and Neuroinflammation on the Hippocampus-A Mini Review Higher cortisol and inflammation markers have been linked specifically to the physical symptoms of depression, like fatigue and appetite changes, more than to the cognitive and emotional symptoms, like guilt or hopelessness.26Molecular Psychiatry. Persistent depressive symptoms, HPA-axis hyperactivity, and inflammation: the role of cognitive-affective and somatic symptoms
Genetically, the field has moved away from looking for a single “depression gene” or “bipolar gene.” Research now points to a polygenic picture in which many small-effect genetic variants add up, and these genetic risk profiles overlap considerably between different mood disorders and even between mood disorders and other psychiatric conditions like schizophrenia and anxiety disorders.27PubMed Central. The Genetic Side of the Mood: A Scientometric Review of the Genetic Basis of Mood Disorders The practical takeaway is that having a family history of one mood disorder raises your risk for several, not just the specific diagnosis your relative has.
When Mood Disorders Are Hard to Tell Apart From Other Conditions
Borderline personality disorder (BPD) is one of the most common sources of diagnostic confusion. People with BPD experience intense mood swings, but these are typically reactive (triggered by interpersonal events) and shorter than the sustained episodes seen in bipolar disorder or MDD. Despite that, mood disorders are extremely common in people with BPD: one large analysis from Taiwan’s national health database found that people with BPD had strikingly elevated rates of both depressive and bipolar disorders compared to control patients.28PubMed Central. Comorbidity study of borderline personality disorder: applying association rule mining to the Taiwan national health insurance research database Anxiety disorders are nearly as common a co-traveler with BPD as mood disorders, and in some studies prove more diagnostically useful for distinguishing BPD from other personality disorders.29PubMed. Axis I comorbidity of borderline personality disorder
The overlap is not just academic. Getting the distinction wrong can lead to medication choices that help one condition while worsening another. Antidepressants prescribed for what looks like MDD, for instance, can sometimes destabilize mood in a person whose underlying condition is actually bipolar II, triggering a hypomanic or mixed episode.
Cultural Variation in How Mood Disorders Present
The list of mood disorders reads as if these conditions show up the same way everywhere, but they do not. When researchers analyzed depressive symptoms across five broad cultural groups, they found real differences in how symptoms clustered. In Latin American populations, feelings of worthlessness tended to group with suicidal thoughts, while in other groups those appeared as separate dimensions. Appetite and weight changes, which Western clinicians often treat as a single symptom, loaded on different factors across cultures.30PubMed. Factor analysis of depression symptoms across five broad cultural groups
Body symptoms versus emotional symptoms represent another cultural fault line. A study comparing Vietnamese and German psychiatric outpatients with similar depression severity found that Vietnamese patients endorsed significantly higher levels of somatic complaints, things like pain, dizziness, and fainting spells, rather than leading with sadness or guilt.31PubMed. Cultural differences in symptom representation for depression and somatization measured by the PHQ between Vietnamese and German psychiatric outpatients Cultural beliefs about the causes of depression also differ. In one comparison study, South Asian participants attributed depression more to personal character or God’s will, while White British participants were more likely to invoke biological explanations like brain chemistry. South Asian participants also expressed greater stigma and social distance toward people with depression.32PubMed Central. Cross‐cultural differences in depression between White British and South Asians: Causal attributions, stigma by association, discriminatory potential These differences affect everything from whether someone seeks help to what kind of treatment they are willing to accept.
Rapid-Acting Treatments and the Glutamate Shift
Traditional antidepressants work mainly on serotonin or norepinephrine and typically take several weeks to produce a meaningful clinical response. Ketamine and its derivatives have upended that timeline. Ketamine can produce antidepressant effects within hours of administration, working through an entirely different brain signaling system that involves glutamate, the brain’s main excitatory neurotransmitter. It acts on receptors that promote the release of brain-derived growth factors and activate pathways that strengthen the connections between neurons.33PubMed Central. Novel Strategies for the Treatment of Depression: Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers Esketamine, a nasal spray derivative, is now approved in many countries for treatment-resistant depression, and the speed of its effect has changed the conversation about what is biologically possible in mood disorder treatment. The fast action is especially relevant for people in acute suicidal crisis, where waiting weeks for a medication to start working is not an acceptable timeline.
Digital Biomarkers and Passive Monitoring
An emerging frontier in mood disorder management is the use of smartphones and wearable devices to track mood states passively. The idea is that changes in behavior that precede or accompany mood episodes, like sleep patterns, activity levels, phone use, and even vocal characteristics, can be picked up by sensors people already carry. Early research in bipolar disorder found that call duration, number of text messages, and self-reported mood and activity data tracked through smartphones correlated with clinician-rated depression and mania scores, and could distinguish between different affective states.34PubMed. Smartphone data as an electronic biomarker of illness activity in bipolar disorder
Speech analysis is another promising angle. Studies using voice recordings have found that features like pitch and the delay before a person begins speaking offer a surprisingly high-fidelity window into bipolar mood dynamics.35medRxiv. Digital Biomarkers for Passive Remote Monitoring of Bipolar Disorder: Systematic Review The broader promise of digital biomarkers is personalized, continuous monitoring that does not depend on a clinic visit or a patient accurately remembering how they felt last week. The technology is still in its early stages, with questions about privacy, data quality, and clinical integration still unresolved, but the trajectory is toward everyday devices becoming clinical tools.36PubMed Central. The implementation of digital biomarkers in the diagnosis, treatment and monitoring of mood disorders: a narrative review
Evolutionary Perspectives on Low Mood
A question that occasionally surfaces when people see the full list of mood disorders is why natural selection would leave humans so vulnerable to conditions this debilitating. Most evolutionary accounts start from the observation that sadness and low mood usually arise in response to adversity, and propose that these states originally served an adaptive purpose. Depression as a clinical disorder, in this view, is what happens when that response overshoots or misfires.37PubMed. Evolutionary theories of depression: a critical review
One influential framework, the Social Navigation Hypothesis, suggests that depressive symptoms evolved to serve two social functions. The withdrawal, rumination, and loss of interest characteristic of depression may force a kind of deep analytical processing of social problems, essentially making the person stop and think harder about what went wrong in a relationship or group dynamic. At the same time, the visible suffering and helplessness of depression may have served as an honest signal to others that the person needs help, making social partners more willing to provide support or make concessions.38PubMed. Toward a revised evolutionary adaptationist analysis of depression: the social navigation hypothesis These ideas remain speculative and are not easy to test directly, but they offer a framework for understanding why the capacity for low mood exists in the first place, even as the clinical extremes clearly cause more harm than good.